← Eichor
Condition: Portal Vein Thrombosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Portal Vein Thrombosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Phase 4 · 1 location(s) · Mansoura University · NCT07132515Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4 · 1 location(s) · Asian Institute Of Medical Sciences · NCT07521332Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein T
Phase 2 · 1 location(s) · First Hospital of China Medical University · NCT07483359TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
NA · 1 location(s) · Sun Yat-sen University · NCT06622031The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT03368651Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis
Phase 2 · 4 location(s) · Seoul National University Hospital · NCT06166576A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation
Phase N/A · 1 location(s) · Ru-zhou Cai · NCT06513780Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT
Phase 2 · 1 location(s) · Yongyi Zeng · NCT06349317TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension
Phase 2 · 1 location(s) · Fei Gao · NCT06646198Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT06904183Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06031285QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT
Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07327788Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma
NA · 2 location(s) · Sun Yat-sen University · NCT06624098PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Tanta University · NCT06960954Freiburg TIPS Registry
Phase N/A · 1 location(s) · University Hospital Freiburg · NCT05782556Indicators Affecting PVT Recanalization
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT07473375SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
Phase 2 · 2 location(s) · Chinese University of Hong Kong · NCT06823375Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT
Phase 3 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT06492395TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05984511Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
NA · 1 location(s) · Northern Jiangsu People's Hospital · NCT07461545BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Phase 2 · 1 location(s) · Shandong Cancer Hospital and Institute · NCT07062055Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
NA · 1 location(s) · Northern Jiangsu People's Hospital · NCT07461532TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06669377Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT
Phase 2 · 1 location(s) · West China Hospital · NCT06664996Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion
Phase 2 · 1 location(s) · Asan Medical Center · NCT05992220Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis
Phase 2 · 6 location(s) · Center Eugene Marquis · NCT07122089
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.